Primary Payer Status Affects Mortality for Major Surgical Operations
Overview
Authors
Affiliations
Objectives: Medicaid and Uninsured populations are a significant focus of current healthcare reform. We hypothesized that outcomes following major surgical operations in the United States is dependent on primary payer status.
Methods: From 2003 to 2007, 893,658 major surgical operations were evaluated using the Nationwide Inpatient Sample (NIS) database: lung resection, esophagectomy, colectomy, pancreatectomy, gastrectomy, abdominal aortic aneurysm repair, hip replacement, and coronary artery bypass. Patients were stratified by primary payer status: Medicare (n = 491,829), Medicaid (n = 40,259), Private Insurance (n = 337,535), and Uninsured (n = 24,035). Multivariate regression models were applied to assess outcomes.
Results: Unadjusted mortality for Medicare (4.4%; odds ratio [OR], 3.51), Medicaid (3.7%; OR, 2.86), and Uninsured (3.2%; OR, 2.51) patient groups were higher compared to Private Insurance groups (1.3%, P < 0.001). Mortality was lowest for Private Insurance patients independent of operation. After controlling for age, gender, income, geographic region, operation, and 30 comorbid conditions, Medicaid payer status was associated with the longest length of stay and highest total costs (P < 0.001). Medicaid (P < 0.001) and Uninsured (P < 0.001) payer status independently conferred the highest adjusted risks of mortality.
Conclusions: Medicaid and Uninsured payer status confers increased risk-adjusted mortality. Medicaid was further associated with the greatest adjusted length of stay and total costs despite risk factors or operation. These differences serve as an important proxy for larger socioeconomic and health system-related issues that could be targeted to improve surgical outcomes for US Patients.
Medicaid Expansion Increases Treatment for Patients with Colon Cancer.
Lyons J, Danos D, Maniscalco L, Yi Y, Moaven O, Wu X Cancers (Basel). 2025; 17(2).
PMID: 39857989 PMC: 11763530. DOI: 10.3390/cancers17020207.
Boyle J, Yau J, Slade J, Butts D, Wimbush J, Park J Cancer Epidemiol Biomarkers Prev. 2024; 33(10):1318-1326.
PMID: 39264110 PMC: 11614192. DOI: 10.1158/1055-9965.EPI-24-0450.
Reisinger R, Caragea M, Teramoto M, Shipman H, Berry-Rieser D, Oli M Interv Pain Med. 2024; 1(2):100073.
PMID: 39239370 PMC: 11372967. DOI: 10.1016/j.inpm.2022.100073.
Cotton C, Goerl B, Kaplan E, Krause M Clin Ophthalmol. 2024; 18:2137-2145.
PMID: 39051021 PMC: 11268748. DOI: 10.2147/OPTH.S452884.
McKechnie T, Jessani G, Bakir N, Lee Y, Sne N, Doumouras A Surg Endosc. 2024; 38(7):4031-4041.
PMID: 38874611 DOI: 10.1007/s00464-024-10965-x.